All the news Showing 10 of 136 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C does not raise risk of heart disease or cancers in people with HIV Keith Alcorn / 18 July 2019 Hepatitis C co-infection does not increase the risk of cardiovascular disease or non-AIDS cancers in people with HIV, an analysis of the large EuroSIDA cohort published in Clinical Infectious Diseases has found. ... NAFLD a rising cause of liver disease in people with HIV Liz Highleyman / 23 April 2019 Now that hepatitis C can be successfully treated, non-alcoholic fatty liver disease (NAFLD) is becoming an increasingly important cause of serious liver problems and liver-related death among people living with HIV in the ... HIV infection an independent risk factor for poorer survival from liver cancer Michael Carter / 28 January 2019 Infection with HIV is associated with significantly worse survival for people with hepatocellular carcinoma (HCC, the most common type of primary liver cancer), according to findings from a large international cohort study published in ... Co-infection with HIV and HCV does not increase the risk of end-stage liver disease or liver cancer Keith Alcorn / 04 January 2019 People with HIV and hepatitis C are no longer at higher risk of end-stage liver disease than people with hepatitis C alone, and the trend is probably associated with the improved effectiveness ... Hepatitis C increases the risk of premature delivery for pregnant women with HIV Keith Alcorn / 08 November 2018 Co-infection with hepatitis C greatly increases the risk of pre-term delivery for pregnant women with HIV, Polish researchers reported last week at the International Congress on Drug Therapy in HIV Infection (HIV ... Majority of US young adults who use drugs are not tested for hepatitis C or HIV Liz Highleyman / 16 October 2018 Only about a third of adolescents and young adults diagnosed with opioid use disorder in the United States are screened for hepatitis C virus (HCV) or HIV, even though injection drug use is ... Hepatitis C elimination in people living with HIV in the UK is feasible by 2021, British HIV Association says Keith Alcorn / 10 October 2018 Hepatitis C co-infection can be eliminated in people living with HIV in the United Kingdom by 2021, the British HIV Association (BHIVA) said today. “The UK can be the first country to achieve ... HIV and chronic HCV co-infection prevalence in England highest among MSM Michael Carter / 20 August 2018 Men who have sex with men (MSM) make up the majority of people with chronic hepatitis C virus (HCV) who have co-infection with HIV, according to data from Public Health England (PHE) published ... Routine clinical use of DAAs highly effective and safe in people with HIV/HCV in Europe Michael Carter / 23 April 2018 “Real life” data from across Europe shows that direct-acting antivirals (DAAs) cure hepatitis C in the vast majority of people with HIV and hepatitis C virus (HCV) co-infection who receive ... 8-week course of Zepatier cures acute HCV in people with HIV Liz Highleyman / 05 April 2018 An 8-week course of grazoprevir/elbasvir (Zepatier) produced sustained virological response in most HIV-positive gay men with recent hepatitis C virus (HCV) genotype 1 or 4 infection, according to a presentation at the ... ← Prev12345...14Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive